Lv1
46 积分 2025-10-27 加入
Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score
1个月前
已完结
Combination strategies in advanced hepatocellular carcinoma: the CARES-310 trial
8个月前
已关闭
Combination strategies in advanced hepatocellular carcinoma: the CARES-310 trial
8个月前
已完结
EGFR activation limits the response of liver cancer to lenvatinib
9个月前
已完结
The Evolving Challenge of Infections in Cirrhosis
10个月前
已完结
Bakterielle und virale Infektionen als Auslöser eines akut-auf-chronischen Leberversagens
10个月前
已完结
A CT-Based Clinical-Radiomics Nomogram for Predicting the Overall Survival to TACE Combined with Camrelizumab and Apatinib in Patients with Advanced Hepatocellular Carcinoma
10个月前
已完结
CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus
10个月前
已完结
Beyond monotherapy: Combining radiotherapy with sintilimab and bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus
10个月前
已完结
Association of triglyceride-glucose index with disease severity in acute pancreatitis and its prognostic role: A prospective observational study
10个月前
已完结
皖公网安备34019202002308
